Biome Bioplastics Limited
USPTO PatentsView assignee record - 9 granted patents across 17 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C08L (Compositions OF Macromolecular Compounds).
The verdict
According to USPTO PatentsView, Biome ranks #28,254 of 49,997 tracked US assignees by granted-patent volume, with 9 patents across 17 technology areas.
- #28,254
- of 49,997 US assignees by volume
- Top 25%
- by Innovation Score (44.7/100)
- 20.3
- avg claims per patent
- +33%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R28254 · Foreign Corporation #28,254 · 9 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · VEL-UP · BOOK-FULL
- GRANTS-MICRO 9 grants
- MID-PACK #28,254/49,997
- PHOTO-FINISH Bind Therapeutics
- CPC-FOCUS C08L · 17 areas
- INNOV-PAR 44.7/100
- CLAIMS-DENSE 20.3 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-UP +33% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Bind Therapeutics, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Biome’s 44.7 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Biome
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Biome Bioplastics · this assignee
Biome Bioplastics · this assignee
45 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Biome's Innovation Score is 44.7/100 (top 25% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Biome?
Each dot is one of Biome’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Biome’s own 20.3 claims/patent is ABOVE the 14.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Biome's grants concentrate
Biome Bioplastics Limited is a focused PatentsView assignee: 17 CPC subclasses with 55.6% of grants classified under C08L (Compositions OF Macromolecular Compounds). Peak complete grant year is 2023 (3 grants) versus a trough of 1 in 2019. By volume, Biome sits between Bind Therapeutics, Inc. and BKS TEC Corp..
Biome's three-year grant acceleration
Biome Bioplastics Limited shows 3 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Biome's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Bind Therapeutics
Bind Therapeutics, Inc.
9 patents
- Bio-path Holdings
Bio-path Holdings, Inc.
9 patents
- Biolab Sanus Farm…
Biolab Sanus Farmaceutica Ltda
9 patents
- Biom'up
Biom'up
9 patents
- Biontech US
Biontech US Inc.
9 patents
- Biotekt USA
Biotekt USA, LLC
9 patents
- Bkon
Bkon LLC
9 patents
- BKS TEC
BKS TEC Corp.
9 patents
- Biome Bioplastics ◀
Biome Bioplastics Limited
9 patents
What this shows Biome holds 9 patents at rank #28,223, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Biome
By rank, the assignees closest to #28,223 in granted patent volume.
- Bind Therapeutics, Inc. #28,219 · 9 patents
- Bio-path Holdings, Inc. #28,220 · 9 patents
- Biolab Sanus Farmaceutica Ltda #28,221 · 9 patents
- Biom'up #28,222 · 9 patents
- Biontech US Inc. #28,224 · 9 patents
- Biotekt USA, LLC #28,225 · 9 patents
- Bkon LLC #28,226 · 9 patents
- BKS TEC Corp. #28,227 · 9 patents
Leaders in C08L (Compositions OF Macromolecular Compounds)
Other assignees with the most granted patents in Biome's primary technology class.
Biome's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
45 Top 25% higher than 75% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 22.2% |
| 2019 | 1 | 11.1% |
| 2020 | 1 | 11.1% |
| 2023 | 3 | 33.3% |
| 2025partial year | 2 | 22.2% |
Which technologies does Biome Bioplastics Limited patent most?
Top 15 of 17 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Biome Bioplastics Limited's patent record in context - here's where to go next.
- Biome Bioplastics Limited's lead technology class is C08L (Compositions OF Macromolecular Compounds), 55.6% of its portfolio - see every assignee active in that class. Explore C08L
- Ranked #28,254 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Biome Bioplastics Limited against Bind Therapeutics, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 44.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.